How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates

被引:5
作者
Franchitto, Nicolas [1 ,2 ,3 ]
Rolland, Benjamin [4 ,5 ]
Pelissier, Fanny [2 ]
Simon, Nicolas [6 ]
机构
[1] Toulouse Purpan Univ Hosp, Dept Addict Med, Toulouse, France
[2] Toulouse Purpan Univ Hosp, Poison Control Ctr, Toulouse, France
[3] Paul Sabatier Univ, UMR 1027, Toulouse, France
[4] SUAL, Pole MOPHA, CH Le Vinatier, Bron, France
[5] Univ Lyon, INSERM, U1028, UCBL,CRNL,CNRS,UMR5292, Lyon, France
[6] Aix Marseille Univ, Hop St Marguerite, AP HM, INSERM,CAP TV,IRD,SESSTIM,Serv Pharmacol Clin, Marseille, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
baclofen; intoxication/pharmacology; comorbid conditions; seizures; psychiatry; HIGH-DOSE BACLOFEN; EXTRACORPOREAL TREATMENT USEFUL; PLACEBO-CONTROLLED TRIAL; SYMPTOMS CASE-REPORT; DEPENDENT PATIENTS; DOUBLE-BLIND; EFFICACY; OVERDOSE; SAFETY; INTOXICATION;
D O I
10.3389/fpsyt.2018.00417
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Specialists in addiction medicine continue to debate whether baclofen is still indicated to treat alcohol use disorders in view of conflicting results as to its efficacy. This review summarizes current knowledge on self-poisoning with baclofen focusing of alcohol-use disorder in order to provide an overview of the reliable scientific knowledge on management of such an intoxication. Moreover, as alcohol-dependent patients experience many psychiatric co-morbidities, the risk in suicide attempt using baclofen seems real. Numerous studies have suggested that patients given daily-doses of baclofen higher than 80 mg/day are more likely to attempt suicides than others. Following an ingestion of a large amount of baclofen, central nervous system depression is usually observed. Seizures require the patient to be admitted in intensive care unit and should be treated like other toxicological seizures. Cardiac complications include prolonged QTc interval, degree heart block, premature atrial contractions, and supraventricular tachycardia, hypotension and bradycardia. In cases of intoxication, the elimination half-life of baclofen may last between 12 and 36 h post-overdose and renal failure is known to delay its clearance. Rarely measured in clinical practice, the toxic level of baclofen blood level ranges from 1.1 to 3.5 mg/l, and coma or fatal intoxication are observed from 6 to 9.6 mg/l. Baclofen withdrawal has been observed but making the diagnosis of withdrawal in case of suspected self-poisoning is difficult as baclofen intoxication and baclofen withdrawal share many clinical signs. Admission to hospital to manage of suicide attempt with baclofen is mandatory and should not be limited to baclofen alone. It needs to include other aspects of the overall care of patients with alcohol disorders (psychological and psychosocial interventions, management of comorbid mental conditions and physical complications).
引用
收藏
页数:6
相关论文
共 50 条
[31]   Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns [J].
Ayal Schaffer ;
Lauren M. Weinstock ;
Mark Sinyor ;
Catherine Reis ;
Benjamin I. Goldstein ;
Lakshmi N. Yatham ;
Anthony J. Levitt .
International Journal of Bipolar Disorders, 5
[32]   Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives [J].
Martinotti, Giovanni ;
Orsolini, Laura ;
Fornaro, Michele ;
Vecchiotti, Roberta ;
De Berardis, Domenico ;
Iasevoli, Felice ;
Torrens, Marta ;
Di Giannantonio, Massimo .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (06) :719-728
[33]   Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns [J].
Schaffer, Ayal ;
Weinstock, Lauren M. ;
Sinyor, Mark ;
Reis, Catherine ;
Goldstein, Benjamin I. ;
Yatham, Lakshmi N. ;
Levitt, Anthony J. .
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2017, 5
[34]   The GABA-B receptor agonist baclofen helps patients with alcohol use disorder: why these findings matter [J].
Leggio, Lorenzo ;
Litten, Raye Z. .
NEUROPSYCHOPHARMACOLOGY, 2021, 46 (13) :2228-2229
[35]   Baclofen for Alcohol Use Disorder: A systematic review and meta-analysis of the randomized clinical trials focusing on safety outcomes [J].
Lefebvre, L. ;
Sanaei, S. ;
Kassai, B. ;
Rolland, B. ;
Auffret, M. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 :129-130
[36]   Role of Acamprosate and Baclofen as Anti-craving Agents in Alcohol Use Disorder: A 12-Week Prospective Study [J].
Sharma, Akhilesh K. ;
Rikhari, Praveen ;
Shukla, Alok K. ;
Rikhari, Pragya .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
[37]   Efficacy of High-Dose Baclofen for Alcohol Use Disorder and Comorbid Bulimia: A Case Report [J].
Weibel, Sebastien ;
Lalanne, Laurence ;
Riegert, Myriam ;
Bertschy, Gilles .
JOURNAL OF DUAL DIAGNOSIS, 2015, 11 (3-4) :203-204
[38]   Systematic review and meta-analysis: Efficacy and safety of baclofen in patients with alcohol use disorder co-morbid liver diseases [J].
Duan, Fangfang ;
Zhai, Hang ;
Liu, Chen ;
Chang, Chunyan ;
Song, Shanshan ;
Li, Junnan ;
Cheng, Jun ;
Yang, Song .
JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 164 :477-484
[39]   A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder [J].
Celik, Muhammet ;
Gold, Mark S. ;
Fuehrlein, Brian .
BRAIN SCIENCES, 2024, 14 (03)
[40]   Characteristics of the patients treated with high dose baclofen in alcohol use disorder: a regional survey conducted in community pharmacies [J].
Auffret, M. ;
Deheul, S. ;
Caous, A. S. ;
Rolland, B. ;
Bene, J. ;
Bordet, R. ;
Gautier, S. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 :44-44